Ghost Tree Capital, LLC Clovis Oncology, Inc. Transaction History

Ghost Tree Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $3.15 Million - $4.68 Million	-75,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $1.25 Million - $1.69 Million	-25,000 Reduced 25.0%	75,000 $3.96 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $5.77 Million - $8.46 Million	100,000	100,000 $6.8 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.